Prot #GR41675: A Phase III, Multicenter, Randomized Study of Efficacy, Safety, and Pharmacokinetics of the Port Delivery System with Ranibizumab in Patients with Diabetic Retinopathy (PAVILION)

Project: Research project

Project Details

StatusActive
Effective start/end date8/21/208/21/23

Funding

  • Genentech, Inc. (Prot #GR41675)